Valuation : Precipio, Inc.

Market Cap 4.68Cr 4.02Cr 3.79Cr 3.46Cr 6.47Cr 441.49Cr 6.49Cr 45Cr 17Cr 226.51Cr 18Cr 17Cr 729.72Cr P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 4.78Cr 4.11Cr 3.87Cr 3.53Cr 6.61Cr 450.95Cr 6.63Cr 46Cr 18Cr 231.37Cr 18Cr 18Cr 745.35Cr EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.32%
Yield 2024 *
-
Yield 2025 -
1 day+4.90%
1 week-5.03%
Current month-1.05%
1 month+20.44%
3 months+17.29%
6 months+2.12%
Current year+19.23%
1 week 24.48
Extreme 24.48
29.9
1 month 21.48
Extreme 21.48
32.57
Current year 19.22
Extreme 19.22
33.63
1 year 16
Extreme 16
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
67.6
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Free

Director

520 0.0291%
15/07/26 Free

Director

416 0.0233%
15/07/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
+4.90%-5.03%+70.19%+315.15% 4.68Cr
-3.10%-5.27%+21.02%-36.05% 1.76TCr
+1.73%+0.02%-35.32%+61.33% 163.35Cr
+0.29%-5.22%-49.73%-82.59% 96Cr
+0.47%-2.36%-23.28%+17.82% 93Cr
-0.05%+0.05%+58.75%-3.84% 78Cr
+0.09%-3.28%-32.69%-47.27% 67Cr
+0.33%+9.47%-35.44%-45.57% 62Cr
-1.01%+5.38%-32.70%-33.45% 49Cr
+0.10%-6.34%+82.73%+48.01% 41Cr
Average +0.42%-2.13%+2.35%+19.35% 241.67Cr
Weighted average by Cap. -1.68%-1.83%+11.06%-26.57%

Financials

2024 2025
Net sales 1.85Cr 1.59Cr 1.5Cr 1.37Cr 2.56Cr 174.97Cr 2.57Cr 18Cr 6.88Cr 90Cr 6.96Cr 6.81Cr 289.2Cr 2.4Cr 2.07Cr 1.95Cr 1.78Cr 3.33Cr 227.06Cr 3.34Cr 23Cr 8.93Cr 116.5Cr 9.03Cr 8.83Cr 375.3Cr
Net income -42.9L -36.92L -34.73L -31.73L -59.35L -41Cr -59.52L -4.1Cr -1.59Cr -21Cr -1.61Cr -1.58Cr -67Cr -4L -3L -3L -3L -5L -3.43Cr -5L -34.73L -13.48L -1.76Cr -13.63L -13.33L -5.66Cr
Net Debt -1L -1L -1L -1L -2L -1.28Cr -2L -13.01L -5L -65.88L -5L -5L -2.12Cr 10.02L 9L 8L 7L 13.86L 9.46Cr 13.9L 95.86L 37.2L 4.85Cr 37.63L 36.81L 16Cr
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
05/26/05 $27.40 +4.90% 1,14,537
03/26/03 $26.12 -5.02% 4,23,788
02/26/02 $27.50 -0.95% 2,37,052
01/26/01 $27.77 +0.27% 2,11,238
31/26/31 $27.69 -4.02% 94,501
  1. Stock Market
  2. Stocks
  3. PRPO Stock